TABLE 1.
Demographic and Clinicopathologic Characteristics, n = 109
| Variable | No. of Patients (% of Total Cohort) |
|---|---|
| Sex | |
| Men | 60 (55) |
| Women | 49 (45) |
| Race | |
| White | 50 (45.9) |
| Black | 45 (41.3) |
| Other | 14 (12.8) |
| Age: Median [range], yrs | 63.6 [23.5–84.8] |
| ASA classification | |
| 2 | 24 (22) |
| 3 | 82 (75.2) |
| 4 | 3 (2.8) |
| Perioperative characteristics | |
| Operation type | |
| Total | 40 (36.7) |
| Subtotal | 69 (63.3) |
| Lymph node dissection type | |
| D0 | 7 (6.4) |
| D1 | 14 (12.8) |
| D2 | 88 (80.7) |
| Pathologic characteristics | |
| Tumor location | |
| GE junction | 14 (12.8) |
| Cardia | 2 (1.8) |
| Body | 64 (58.7) |
| Antrum | 28 (26.6) |
| Tumor size: Median [range], cm | 4.0 [0.2–15.0] |
| Resection margin | |
| R0 | 102 (93.6) |
| R1 | 7 (6.4) |
| Tumor grade | |
| 1: Well differentiated | 5 (4.6) |
| 2: Moderately differentiated | 30 (27.5) |
| 3: Poorly differentiated | 74 (67.9) |
| Tumor type | |
| Diffuse | 18 (16.4) |
| Intestinal | 31 (28.2) |
| Signet ring histology | 57 (52.3) |
| Tumor classification: AJCC 7th edition | |
| T1a | 4 (3.7) |
| T1b | 15 (13.8) |
| T2 | 13 (11.9) |
| T3 | 39 (35.8) |
| T4a | 30 (27.5) |
| T4b | 8 (7.3) |
| TNM stage: AJCC 7th edition | |
| I | 24 (22) |
| II | 31 (28.4) |
| III | 53 (48.6) |
| Lymphovascular invasion | 37 (33.9) |
| Perineural invasion | 25 (22.9) |
| Lymph node-positive disease | 68 (62.4) |
| Perioperative Treatment characteristics | |
| Any adjuvant treatment: Preoperative or postoperative | 73 (66.9) |
| Neoadjuvant chemotherapy | 16 (14.7) |
| Neoadjuvant radiotherapy | 3 (2.7) |
| Adjuvant chemotherapy | 70 (64.2) |
| Adjuvant radiotherapy | 50 (45.8) |
Abbreviations: ASA, American Society of Anesthesiologists; GE, gastroesophageal.